Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas.
Am J Perinatol. 2021 Jul;38(9):976-982. doi: 10.1055/s-0039-1701023. Epub 2020 Jan 27.
The centuries-old approach to the prevention of eclampsia and its associated maternal morbidity and mortality is based on the recognition of the presence of premonitory signs and symptoms such as hypertension and proteinuria. The spectrum of preceding signs and symptoms came to be known as preeclampsia, which is debatably considered to be an early stage on a clinical continuum possibly leading to eclampsia. The premonitory signs and symptoms were then construed as diagnostic criteria for the poorly understood syndrome of preeclampsia, and this led to a perpetual debate that remains subject to wide disagreement and periodic updates. In this commentary, we will draw attention to the fact that the criteria for preeclampsia should be viewed from the prism of a screening test rather than as diagnostic of a condition in itself. Focusing research on developing better diagnostic and screening methods for what is clinically important, namely maternal and perinatal morbidity and mortality from hypertensive disorders of pregnancy, a long overdue upgrade from what was possible centuries ago, will ultimately lead to better management approaches to what really matters.
几个世纪以来,预防子痫前期及其相关的孕产妇发病率和死亡率的方法是基于对先兆征象和症状(如高血压和蛋白尿)的认识。这些先前的征象和症状被称为子痫前期,它被认为是一种可能导致子痫的临床连续体的早期阶段,这是有争议的。这些先兆征象和症状随后被解释为子痫前期这一尚未完全了解的综合征的诊断标准,这导致了一场持续的争论,至今仍存在广泛的分歧和定期更新。在这篇评论中,我们将提请注意这样一个事实,即子痫前期的标准应该从筛查试验的角度来看待,而不是作为一种疾病的诊断标准。将研究重点放在开发更好的诊断和筛查方法上,这些方法对于临床上重要的问题,即妊娠高血压疾病的孕产妇和围产儿发病率和死亡率,这是一个早已被忽视的问题,需要从几个世纪前的水平进行升级,这最终将导致对真正重要问题的更好的管理方法。